Revenue, 2024 (US$M)
$0.0
Forecast, 2030 (US$M)
$0.0
CAGR, 2025 - 2030
0%
Report Coverage
U.S.

U.S. dna diagnostics market, 2018-2030 (US$M)

U.S.

U.S. dna diagnostics market highlights

  • The U.S. dna diagnostics market generated a revenue of USD 3,522.8 million in 2023 and is expected to reach USD 4,135.5 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 2.3% from 2024 to 2030.
  • In terms of segment, pcr-based diagnostics was the largest revenue generating technology in 2023.
  • NGS DNA Diagnosis is the most lucrative technology segment registering the fastest growth during the forecast period.


Dna diagnostics market data book summary

Market revenue in 2023USD 3,522.8 million
Market revenue in 2030USD 4,135.5 million
Growth rate2.3% (CAGR from 2023 to 2030)
Largest segmentPcr-based diagnostics
Fastest growing segmentNGS DNA Diagnosis
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPCR-based Diagnostics, NGS DNA Diagnosis, In-Situ Hybridization Diagnostics, Microarrays-based Diagnostics
Key market players worldwideGE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Hologic Inc, Siemens Healthineers AG ADR, Roche, Qiagen NV, Agilent Technologies Inc


Other key industry trends

  • In terms of revenue, U.S. accounted for 33.1% of the global dna diagnostics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. dna diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 1,319.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

DNA Diagnostics Market Scope

Dna diagnostics market segmentation & scope
PCR-based Diagnostics
NGS DNA Diagnosis
In-Situ Hybridization Diagnostics
Microarrays-based Diagnostics
Application
Cancer Genetics Tests
Infectious Diseases DNA Testing
HBV Diagnostic
HCV Diagnostic
HIV Diagnostic
TB Diagnostic
CT/NG Diagnostic
HPV Diagnostic
MRSA Diagnostic
Others Infectious Disease Diagnostic
Newborn Genetic Screening
Preimplantation & Reproductive Diagnosis
Non-Infectious Diseases DNA Testing
Cardiovascular Diseases
CNS & PNS Related
Skeletal, Connective, Ectodermal & Dermal DNA Testing
Lung, Kidney, Liver & GT Related
Sensory Diseases
Prenatal DNA Carrier Screening
Pharmacogenomics/Drug Metabolism
Hematology & Immunology/Identity Diagnostics & Forensics
Other Applications
Countries
Mexico
UK
Spain
France
Italy
Denmark
Sweden
Norway
India
South Korea
Australia
Thailand
Argentina
Saudi Arabia
UAE
Kuwait

DNA Diagnostics Market Companies

Name Profile # Employees HQ Website

U.S. dna diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna diagnostics market will help companies and investors design strategic landscapes.


Pcr-based diagnostics was the largest segment with a revenue share of 49.93% in 2024. Horizon Databook has segmented the U.S. dna diagnostics market based on pcr-based diagnostics, ngs dna diagnosis, in-situ hybridization diagnostics, microarrays-based diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.


The U.S. is expected to be the largest market for DNA diagnostics in North America due to the high cancer prevalence in the country and consequent rapid adoption of diagnostic tests. Some other factors propelling market growth in the country include the increasing prevalence of genetic disorders and the growing emphasis on personalized medicine. 

As healthcare shifts toward tailored treatments, genetic testing plays a critical role in identifying the right therapies for patients. In addition, significant technological advancements, an increasing number of FDA approvals for tests, and competition among biotechnology companies are projected to boost the market over the forecast period. 

Moreover, according to an article published by the National Library of Medicine in April 2023, over the past two decades, genetic testing has grown in popularity around the world. The U.S. established the Genetic Testing Registry (GTR) in response to the swift advancement of genetic tests, with the aim of facilitating public access to data regarding genetic tests and the associated labs.

Reasons to subscribe to U.S. dna diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. dna diagnostics market databook

  • Our clientele includes a mix of dna diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. dna diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. dna diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. dna diagnostics market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more